openPR Logo
Press release

Global Cushing’s syndrome Market Analysis and Forecast 2017 - 2025 Explored in Latest Research

Global Cushing’s syndrome Market Analysis and Forecast 2017 -

Cushing’s syndrome is the collection of symptoms caused due to the high level of hormones called cortisol. Also known as hypercortisolism, the syndrome is often caused due to side effects of corticosteroid treatment. Corticosteroids are often used for treatment of inflammation and autoimmune conditions. Cushing’s syndrome can be of two types, iatrogenic Cushing’s syndrome and endogenous Cushing’s syndrome. Common symptoms of the syndrome include weight gain, fat tissue deposits around midsection and back, purple stretch marks, thinning skin which can be easily bruised, acne etc.

View TOC for this Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=30617

The global Cushing’s syndrome market is expect to expand at a robust CAGR during the forecast period. Cushing’s syndrome is a rare disease and according to UCLA Health, the syndrome affects 10 to 15 people per million each year. Increasing prevalence of the disease is one of the important factors projected to drive the global Cushing’s syndrome market through 2025. Surge in prevalence of chronic diseases leading to increase in usage of corticosteroids is another factor likely to drive the market during the forecast period.

The launch of novel drugs such as steroidogenesis inhibitors for treatment of Cushing’s syndrome is the key factor projected to propel the growth of the global Cushing’s syndrome market during the forecast period. Furthermore, unhealthy lifestyle, increase in geriatric population, and steroid abuse are factors attributed to the growth of the market. Difficulties in diagnosis, sparsely populated pipeline products, strict regulations etc are factors restraining the growth of the global Cushing’s syndrome market.

The global Cushing’s syndrome market can be segmented into type, treatment, end users, and geographical expansion. On the basis of disease type, the market can be divided into iatrogenic Cushing’s syndrome and endogenous Cushing’s syndrome. On the basis of treatment, the market is divided into surgery, radiation therapy, drugs and others.

The drugs segment is further divided into drug types such as Ketoconazole, Etomidate, Pasireotide, Aminoglutethimide and others. The drug segment is expected to hold a significant share during the forecast period due to factors such as effectiveness of drugs, their noninvasive nature, and fewer side effects than radiation therapies. The global Cushing’s syndrome market, on the basis of end users is segmented into hospitals, clinics, home care settings and others.

Geographically the Cushing’s syndrome market is divided into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the market with the largest share in the global Cushing’s syndrome market. Increase in prevalence of obesity in young adults and children in the region leading to Cushing’s syndrome is one of the major factors driving the growth of the market in the region. Furthermore, advanced technology, rise in awareness among people about diagnosis of the disease, high healthcare expenditure etc. are some of the factors attributed to the growth of the North America Cushing’s syndrome market.

For more information on this report, fill the form @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30617

Europe is also anticipated to hold a significant share of the global market, after North America. The Asia Pacific market is anticipated to register a faster growth rate during the forecast period. Asia Pacific is the most lucrative market due to growing geriatric population, adoption of healthcare solutions for better standard of life, rise in awareness about healthcare, prevalence of lifestyle related diseases etc.

To maintain a significant position in the market, key players in the global Cushing’s syndrome market are operating strategies such as mergers and acquisitions, cost effective and efficient drugs, collaborative partnerships etc. Some of the prominent players operating in the Cushing’s syndrome market are Novartis Pharmaceuticals Corporation, Corcept Therapeutics, HRA Pharma and others.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cushing’s syndrome Market Analysis and Forecast 2017 - 2025 Explored in Latest Research here

News-ID: 791671 • Views: 122

More Releases from Transparency Market Research

High Nutritional Content Fuelling Demand For Yogurt Market
Rising awareness about the benefits of yogurt over curd is propelling the demand for yogurt among consumers Yogurt has lower sugar and fat content, making it preferable for health conscious customers. Besides, manufacturers are boosting the nutrition value by adding minerals, vitamins, and fiber in the product. For example, Arla foods, a food manufacturing company, has recently introduced fiber-rich yogurt. The yogurt has high protein content, adequate amount of
Increasing Inclination Towards Healthy Lifestyle To Propel Protein Supplements M …
According to a new report by Transparency Market Research (TMR), a leading market intelligence firm, the global protein supplements market is witnessing a tremendous rise in its valuation, thanks to the increased focus of consumers towards acquiring a healthy lifestyle. With the presence of a large number of players, such as GlaxoSmithKline Plc, Amway Corp., ABH Pharma Inc., Vitacost.com Inc., and Nu Skin Enterprises Inc., the competitive landscape in the
Ginger Market is expected to reach a valuation of US$4.18 bn by the end of 2022
The global reach and acceptance for spices, especially for ginger have been increasing in recent years, presenting promising growth opportunities for large-scale manufacturers and processors of the spice that also promises vast health benefits, observes Transparency Market Research in a recent report. The global ginger market has multiple players, owing to which the vendor landscape is fragmented and is competitive in nature. Read report Overview- https://www.transparencymarketresearch.com/ginger-market.html The dominant players in the global
Feather Meal Market: Import-Export, Industry Chain Structure and Development Opp …
A recent study published by Transparency Market Research on the feather meal market includes global industry analysis and opportunity assessment for 2020-2030. Revenue generated from the global feather meal market was valued at US$ 359.5 Mn in 2020, which is estimated to rise at a CAGR of 8.6%, to reach ~US$ 820 Mn by 2030. Obtain Report Details @ https://www.transparencymarketresearch.com/feather-meal-market.html global feather meal market Nutritive Value of Feather Meal to Influence Feather

All 5 Releases


More Releases for Cushing’s

Cushing’s Syndrome Therapeutics - Key Players Analysis Novartis, AstraZeneca, …
The study analyzed that the Cushing’s syndrome therapeutics pipeline comprises of approximately 13 drug candidates. Browse report sample at: https://www.psmarketresearch.com/market-analysis/cushing-syndrome-therapeutics-pipeline-analysis/report-sample *Specific Targeted Therapy to Provide Various Opportunities The drug development process involves specific target such as steroid 11-beta-hydroxylase, which is the probable mechanism of action for the treatment of Cushing’s syndrome. Thus, this specific targeted therapy provides opportunities to the companies for better and targeted drug development. Some of the players developing drugs
Cushing’s Disease Treatment Market Expecting Worldwide Growth by 2025
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease
Cushing’s Syndrome Therapeutics Pipeline Analysis by Drug Profile, Top Industr …
The study analyzed that the Cushing’s syndrome therapeutics pipeline comprises of approximately 13 drug candidates. Orphan drug designations from the European Medicines Agency (EMA) is the one of the drivers for the development of pipeline drugs of Cushing’s syndrome. Majority of the pipeline drug candidates are being developed using the oral route of administration. Osilodrostat which is being developed by the Novartis AG is in the Phase III stage of development
Cushing’s Disease Treatment Market to Develop Rapidly by 2025
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease
Cushing’s syndrome Market Size and Industry Forecast 2025 - Market Shares and …
"The Latest Research Report Cushing’s syndrome Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Cushing’s syndrome is the collection of symptoms caused due to the high level of hormones called cortisol. Also known as hypercortisolism, the syndrome is often caused due to side effects of corticosteroid treatment. Corticosteroids
Cushing’s Disease Treatment Market is Expecting Worldwide Growth by 2017 – 2 …
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease